Loading...
Loading...
QGEN| Name | Value |
|---|---|
| Revenues | 494.9M |
| Cost of Revenue | 182.7M |
| Gross Profit | 312.2M |
| Operating Expense | 198.1M |
| Operating I/L | 105.4M |
| Other Income/Expense | -3.1M |
| Interest Income | 21.3M |
| Pretax | 102.3M |
| Income Tax Expense | 21.5M |
| Net Income/Loss | 80.8M |
QIAGEN N.V. offers a wide range of sample to insight solutions for transforming biological materials into molecular insights. The company provides primary and secondary sample technology consumables, instruments for nucleic acid purification, interferon-gamma release assay for TB testing, assays for prenatal testing, and sample to insight instruments. Additionally, it offers PCR consumables, human ID and forensics assay consumables, PCR instruments, NGS gene panels, bioinformatics solutions, and custom laboratory and genomic services. QIAGEN serves customers in molecular diagnostics, academia, pharmaceutical, and applied testing sectors, generating revenue through the sale of consumables, instruments, and services.
